NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 105 filers reported holding NEWLINK GENETICS CORP in Q4 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |